Zhi-en Zhou

发表

Prognostic significance of a novel indicator (PSApostd3/PSApre) for PSA recurrence in patients after radical prostatectomy

Yi Zhou, Yinyan Xu, Han-Zhong Li, 2019, Cancer management and research.

Prognostic signi fi cance of a novel indicator ( PSApostd 3 / PSApre ) for PSA recurrence in patients after radical prostatectomy

Yi Zhou, Yinyan Xu, Han-Zhong Li, 2019 .

Renal myopericytoma : a case report and literature review

Han-Zhong Li, Z. Ji, Zhi-en Zhou, 2018 .

Development of a nomogram combining multiparametric magnetic resonance imaging and PSA‐related parameters to enhance the detection of clinically significant cancer across different region

Yi Zhou, Z. Ji, Han-Zhong Li, 2022, The Prostate.

A Multicenter Single-Arm Objective Performance Criteria Trial to Determine the Efficacy and Safety of High-Frequency Irreversible Electroporation as Primary Treatment for Localized Prostate Cancer: A Study Protocol

Yanqing Wang, S. Ren, B. Dong, 2021, Frontiers in Oncology.

The characteristics and spatial distributions of prostate cancer in autopsy specimens

Yi Zhou, Han-Zhong Li, Z. Ji, 2020, The Prostate.

Transperineal template‐guided prostate biopsy: 10 years of experience

Zhiyong Liang, Yi Zhou, Han-Zhong Li, 2016, BJU international.

Treatment outcomes of 125I low-dose-rate brachytherapy vs radical prostatectomy for patients with intermediate-risk prostate cancer

Yi Zhou, Han-Zhong Li, Z. Ji, 2020 .

Unilateral lesion detected on preoperative multiparametric magnetic resonance imaging and MRI/US fusion-guided prostate biopsy is not an appropriate indication for focal therapy in prostate cancer.

Yi Zhou, Han-Zhong Li, Z. Ji, 2021, Urologic oncology.

Comparison of lesions detected and undetected by template‐guided transperineal saturation prostate biopsy

Zhiyong Liang, Yi Zhou, Han-Zhong Li, 2018, BJU international.

Tetramethylpyrazine reduces prostate cancer malignancy through inactivation of the DPP10‑AS1/CBP/FOXM1 signaling pathway.

Yi Zhou, Han-Zhong Li, Z. Ji, 2020, International journal of oncology.

Unexpected hemorrhage of a rare vessel, a pubic branch of the external iliac artery, after laparoscopic radical prostatectomy: Case report

Z. Ji, Zhi-en Zhou, Jie Pan, 2017, Medicine.

Long non‐coding RNA ADAMTS9‐AS1 inhibits the progression of prostate cancer by modulating the miR‐142‐5p/CCND1 axis

Yi Zhou, Zhi-en Zhou, Xing-cheng Wu, 2021, The journal of gene medicine.

A Risk Score Model Based on Nine Differentially Methylated mRNAs for Predicting Prognosis of Patients with Clear Cell Renal Cell Carcinoma

Z. Ji, Zhi-en Zhou, Guanghua Liu, 2021, Disease markers.

lncRNA SNHG20 promotes prostate cancer migration and invasion via targeting the miR-6516-5p/SCGB2A1 axis.

Yi Zhou, Zhi-en Zhou, Yu Xiao, 2019, American journal of translational research.

Tetramethylpyrazine inhibits prostate cancer progression by downregulation of forkhead box M1

Yi Zhou, Han-Zhong Li, Z. Ji, 2017, Oncology reports.

The biological functions and mechanism of miR-212 in prostate cancer proliferation, migration and invasion via targeting Engrailed-2

Yi Zhou, Han-Zhong Li, Z. Ji, 2017, Oncology reports.

LncRNA FOXP4-AS1 is activated by PAX5 and promotes the growth of prostate cancer by sequestering miR-3184-5p to upregulate FOXP4

Yi Zhou, Zhi-en Zhou, Yu Xiao, 2019, Cell Death & Disease.

Identification of UAP1L1 as a critical factor for prostate cancer and underlying molecular mechanism in tumorigenicity

Xian-lu Song, Shan-Chao Zhao, Zhi-en Zhou, 2022, Journal of Translational Medicine.

Long-term outcome of High-risk Prostate Cancer Treated with Brachytherapy Combined with External-beam Radiation Therapy and Androgen Deprivation Therapy

Yi Zhou, Han-Zhong Li, Z. Ji, 2014, Tumori.

Diagnostic accuracy of magnetic resonance-guided prostate biopsy and template-guided transperineal saturation biopsy

Yi Zhou, Yinyan Xu, Han-Zhong Li, 2018, Medicine.

Bilateral Adrenal Tumors from Different Histology: Case Report and Literature Review

Jianchun Xiao, Yi Zhou, Han-Zhong Li, 2014, Cell Biochemistry and Biophysics.

Bilateral Adrenal Tumors from Different Histology: Case Report and Literature Review

Jianchun Xiao, Yi Zhou, Han-Zhong Li, 2014, Cell Biochemistry and Biophysics.

Re: Stephanie Guillaumier, Max Peters, Manit Arya, et al. A Multicentre Study of 5-year Outcomes Following Focal Therapy in Treating Clinically Significant Nonmetastatic Prostate Cancer. Eur Urol 2018;74:422-9.

Yi Zhou, Zhi-en Zhou, W. Yan, 2019, European urology.

The transverse and vertical distribution of prostate cancer in biopsy and radical prostatectomy specimens

Yi Zhou, Z. Ji, Zhi-en Zhou, 2018, BMC Cancer.

Padeliporfin vascular-targeted photodynamic therapy versus active surveillance in men with low-risk prostate cancer.

Weigang Yan, Yi Zhou, Yi Zhou, 2017, The Lancet. Oncology.

Comparison of PI-RADS version 2.1 and PI-RADS version 2 regarding interreader variability and diagnostic accuracy for transition zone prostate cancer

Zhengyu Jin, Yi Zhou, Zhi-en Zhou, 2020, Abdominal Radiology.

Re: Transperineal Template Guided Prostate Biopsy Selects Candidates for Active Surveillance-How Many Cores are Enough?: K. N. Pham, C. R. Porter, K. Odem-Davis, E. M. Wolff, C. Jeldres, J. T. Wei and T. M. Morgan J Urol 2015;194:674-679.

Z. Ji, Zhi-en Zhou, W. Yan, 2016, The Journal of urology.

Development and internal validation of a prediction model of prostate cancer on initial transperineal template-guided prostate biopsy

Yi Zhou, Z. Ji, Zhi-en Zhou, 2021, BMC Urology.

Tumor characteristics, treatments, and survival outcomes in prostate cancer patients with a PSA level < 4 ng/ml: a population-based study

Yi Zhou, Z. Ji, Zhi-en Zhou, 2020, BMC Cancer.

125I low-dose-rate prostate brachytherapy and radical prostatectomy in patients with prostate cancer.

Yi Zhou, Z. Ji, Fuquan Zhang, 2019, Oncology letters.

I low ‐ dose ‐ rate prostate brachytherapy and radical prostatectomy in patients with prostate cancer

J. Zhigang, Yi Zhou, Fuquan Zhang, 2022 .

The direct prognosis comparison of 125I low-dose-rate brachytherapy versus laparoscopic radical prostatectomy for patients with intermediate-risk prostate cancer

Yi Zhou, Zhi-en Zhou, Xing-cheng Wu, 2023, European Journal of Medical Research.

An Unusual Right-sided Suprarenal Accessory Spleen Misdiagnosed as an Atypical Pheochromocytoma.

Zenan Xia, Z. Ji, Zhi-en Zhou, 2017, Urology.

Outcomes of T3a Prostate Cancer with Unfavorable Prognostic Factors Treated with Brachytherapy Combined with External Radiotherapy and Hormone Therapy.

Yi Zhou, Zhi-en Zhou, Zhi-peng Mai, 2015, Chinese medical sciences journal = Chung-kuo i hsueh k'o hsueh tsa chih.

Indications, strategies, and development on prostate targeted biopsy: Report of the Panjiayuan Consensus Conference 2022

N. Xu, Baojun Wang, Hongliang Shen, 2023, UroPrecision.

Long-term outcome of early stage prostate cancer treated with brachytherapy analysis after a mean follow-up of 7 years

Yi Zhou, Z. Ji, Fuquan Zhang, 2014, SpringerPlus.

Artificial intelligence-based model for lymph node metastases detection in bladder cancer.

Wei Yan, Yi Zhou, Zhi-en Zhou, 2023, The Lancet Oncology.

LncRNA FOXP4-AS1 is activated by PAX5 and promotes the growth of prostate cancer by sequestering miR-3184-5p to upregulate FOXP4

Yi Zhou, Zhi-en Zhou, Yu Xiao, 2019, Cell Death & Disease.

Re: Jeffrey J. Tosoian, Debasish Sundi, Bruce J. Trock, et al. Pathologic Outcomes in Favorable-risk Prostate Cancer: Comparative Analysis of Men Electing Active Surveillance and Immediate Surgery. Eur Urol 2016;69:576-81.

Zhi-en Zhou, W. Yan, Hanzhong Li, 2017, European urology.

Long-term outcome of High-risk Prostate Cancer Treated with Brachytherapy Combined with External-beam Radiation Therapy and Androgen Deprivation Therapy

Yi Zhou, Z. Ji, Zhi-en Zhou, 2014, Tumori.

The transverse and vertical distribution of prostate cancer in biopsy and radical prostatectomy specimens

Yi Zhou, Z. Ji, Zhi-en Zhou, 2018, BMC Cancer.